Clinical Trials Browser

Phase 2 × mirdametinib × 30 days × Clear all

Arteriovenous Malformations, Lymphangioma, Skin Diseases, Vascular, Lymphangioma, Cystic, Lymphatic Abnormalities, Vascular Malformations